期刊文献+

气相色谱-质谱联用法检测保健品中4种PDE-5抑制剂药物 被引量:7

Detection of Four PDE-5 Inhibitors in Nutriment Products by GC/MS
在线阅读 下载PDF
导出
摘要 采用气相色谱-质谱联用法同时检测保健品中的他达那非(tadalafil),西地那非(sildenafil),好猫西地那非(homosildenafil),伐地那非(vardenafil)。用乙酸乙酯提取,HP-1MS色谱柱(17m×0.2mm×0.11mm)分离,程序升温,质谱检测。该方法的检测限能满足保健品日常检测的要求,前处理简单、快速、可靠。 Total of 4 PDE-5 inhibitors (tadalafil, sildenafil, homosildenafil, vardenafil) were simultaneously detected by gas chromatography-mass spectrometry coupling with electronic ionization. The sample was extracted with the ethyl acetate and completely separated by HP-1MS column (17m ×0.2 mm×0.11mm) in linear temperature program. The method is simple, rapid and reliable. It is suitable for screening PDE-5 inhibitors in routine analysis for nutriment products.
出处 《质谱学报》 EI CAS CSCD 2009年第5期278-281,共4页 Journal of Chinese Mass Spectrometry Society
关键词 保健品 气相色谱-质谱 PDE-5抑制剂 nutriment gas chromatography-mass spectrometry PDE-5 inhibitor
  • 相关文献

参考文献4

  • 1PENG Z, SHARON S Y, PEILING H, etal. Simultaneous determination of synthetic phosphodiesterase-5 inhibitors found in a dietary supplement and pre-mixed bulk powders for dietary supplements using high-performance liquid chromatography with diode array detection and liquid chromatography-electrosp ray ionization tandem mass spectrometry[J]. J Chromatogr A, 2006, 1 104: 113-122.
  • 2STARK S , SACHASE R , STARK A, et al. Erectile response on visual sexual stimulation after 20 mg or 40 rag Bay 38-9456 or placebo[J]. Eur Urol, 2000, 37 (S2): 15-18.
  • 3陈巧云,王楠,姚峰,陆晓和.磷酸二酯酶5抑制剂治疗勃起功能障碍的疗效和安全性比较[J].中华男科学杂志,2004,10(4):302-304. 被引量:3
  • 4张杰,杨吉伟,张炜.伐地那非与勃起功能障碍[J].世界临床药物,2004,25(2):94-98. 被引量:4

二级参考文献11

  • 1Summary of product characteristics[M]. London:Lilly Icos Limited, 2002.6-5.
  • 2Coleman CI, Carabino JM, Vergara CM, et al. Vardenafil an oral selective phosphodiesterase 5 inhibitor for the treatment of erectile dysfunction [ J ]. Formulary, 2003, 38 ( ) : 131-148.
  • 3Hellstrom WJ, Gittelman M, Karlin G, et al. Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in arandomized, doable-blind, placebo-controlled trial[ J ]. J Androl,2002, 23(6) :763-771.
  • 4Brock GB, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil for the treatment of erectile dysfunction : results of integrated analysis[J]. J Urol, 2002, 168(4 Pt 1 ):1332-1336.
  • 5Padma-Nathan H, Eardley I, Kloner RA, et al. A 4-year update on the safety of sildenafil citrate (Viagra)[J]. Urology, 2002,60(Suppl 2B) :67-90.
  • 6Gresser U, Gleiter CH. Erectile dysfunction : comparison of efficacy and side effects of the PDE5 inhibitors sildenafil, vardenafil,and tadalafil review of the literature[ J ]. Eur J Med Res,2002, 7(10) :435-446.
  • 7Steers WD. Pharmacologic treatment of erectile dysfunction[J].Rev Urol, 2002, 4(Sp 3):S17-S25.
  • 8T. Klotz,R. Sachse,A. Heidrich,F. Jockenh?vel,G. Rohde,G. Wensing,R. Horstmann,R. Engelmann. Vardenafil increases penile rigidity and tumescence in erectile dysfunction patients: a RigiScan and pharmacokinetic study[J] 2001,World Journal of Urology(1):32~39
  • 9郭应禄,朱积川,潘天明,曹坚,江鱼,王益鑫,姚德鸿,胡礼泉.口服西地那非治疗勃起功能障碍疗效和安全性的临床研究[J].中华泌尿外科杂志,2001,22(7):389-394. 被引量:53
  • 10吴新荣,张延军.应用枸橼酸西地那非值得注意的问题[J].中国医院药学杂志,2002,22(6):366-368. 被引量:5

共引文献4

同被引文献884

引证文献7

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部